Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Arboretum Ventures

Investor type Venture Capital
Founders Jan Garfinkle Tim Petersen


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 93
Average round size
The average size of a deal this fund participated in
Portfolio companies 55
Rounds per year 4.65
Lead investments 13
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 21
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical

Arboretum Ventures is the famous VC, which was founded in 2002. The venture was found in North America in United States. The main office of represented VC is situated in the Ann Arbor.

The current fund was established by Jan Garfinkle, Tim Petersen. We also calculated 4 valuable employees in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Arboretum Ventures, startups are often financed by Chrysalis Ventures, Lumira Ventures, ONSET Ventures. The meaningful sponsors for the fund in investment in the same round are Chrysalis Ventures, Baird Capital, ONSET Ventures. In the next rounds fund is usually obtained by Lumira Ventures, ONSET Ventures, Flagship Pioneering.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2018. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Arboretum Ventures performs on 9 percentage points less the average number of lead investments. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity.

Among the most successful fund investment fields, there are Medical, Hospital. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cardiac Dimensions, NeuMoDx Molecular, Delphinus Medical Technologies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Arboretum Ventures:
Typical Co-investors
Arboretum Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Arboretum Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Boomerang Medical

$15M01 Nov 2022 Mountain View, California, United States

Delphinus Medical Technologies

Health Care
Medical Device
$30M13 Sep 2022 Michigan, United States

Navv Systems

Health Care
$5M18 Aug 2022 Detroit, Michigan, United States

Enumera Molecular

Life Science
$12M05 May 2022 Ann Arbor, Michigan, United States

Koya Medical

Health Care
$26M03 Feb 2022 Oakland, California, United States


Health Care
Medical Device
$27M19 Nov 2021 Corona Del Mar, California, United States

Convergent Dental

Health Care
Medical Device
$40M29 Oct 2021 Massachusetts, United States

Boomerang Medical

$3M18 Oct 2021 Mountain View, California, United States

Akadeum Life Sciences

Information Technology
$17M12 Oct 2021 Ann Arbor, Michigan, United States
Convergent Dental Raises $40M in Series C Funding

– Convergent Dental, a Needham, MA-based developer of a laser to enable anesthesia-free, pain-free dentistry, raised $40m in Series C round.
– The round was led by Arboretum Ventures, with participation from existing investors, including Long River Ventures and the Gund Foundation.
– The new investment will be used to expand the company’s product portfolio and increase investment in market development.

Francis Medical Raises $55M in Series B Equity Funding

– Francis Medical, a Minneapolis MI-based medical device company, raised $55M in Series B equity funding.
– The round was led by Solas BioVentures with participation from Arboretum Ventures, Coloplast A/S, H2Oey Ventures and Tonkawa.
– The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Arboretum Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: